Analysis of heterogeneity in T2-weighted MR images can differentiate pseudoprogression from progression in glioblastoma

Abstract

Analysis of heterogeneity, in T2-weighted MR images, which are acquired routinely in the clinic, has the potential to detect an earlier treatment response allowing an early change in treatment strategy. Prospective validation of this technique in larger datasets is required.